Medprin Regenerative Medical Technologies Co., Ltd. Stock
Equities
301033
CNE100004NB8
Medical Equipment, Supplies & Distribution
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
41.51 CNY | +0.61% | +3.23% | -4.66% |
Sales 2024 * | 288M 39.77M | Sales 2025 * | 377M 52.03M | Capitalization | 2.74B 379M |
---|---|---|---|---|---|
Net income 2024 * | 67M 9.25M | Net income 2025 * | 105M 14.5M | EV / Sales 2024 * | 9.52 x |
Net cash position 2024 * | - 0 | Net cash position 2025 * | - 0 | EV / Sales 2025 * | 7.28 x |
P/E ratio 2024 * |
40.3
x | P/E ratio 2025 * |
26.1
x | Employees | 278 |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 38.47% |
1 day | +0.61% | ||
1 week | +3.23% | ||
1 month | +20.32% | ||
3 months | +34.55% | ||
6 months | -7.76% | ||
Current year | -4.66% |
Managers | Title | Age | Since |
---|---|---|---|
Yu Yu Yuan
CEO | Chief Executive Officer | 44 | 08-08-31 |
Ya Hong Luo
DFI | Director of Finance/CFO | 56 | 17-01-31 |
Kun Xue Deng
CTO | Chief Tech/Sci/R&D Officer | - | 11-09-30 |
Members of the board | Title | Age | Since |
---|---|---|---|
Xin Lu
BRD | Director/Board Member | 61 | 18-10-31 |
Yu Yu Yuan
CEO | Chief Executive Officer | 44 | 08-08-31 |
Ya Hong Luo
DFI | Director of Finance/CFO | 56 | 17-01-31 |
Date | Price | Change | Volume |
---|---|---|---|
24-05-31 | 41.51 | +0.61% | 613,200 |
24-05-30 | 41.26 | -1.06% | 495,008 |
24-05-29 | 41.7 | +1.71% | 621,000 |
24-05-28 | 41 | -0.61% | 507,500 |
24-05-27 | 41.25 | +2.59% | 705,100 |
End-of-day quote Shenzhen S.E., May 30, 2024
More quotesEPS Revisions
Annual profits - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
-4.66% | 379M | |
+13.73% | 130B | |
-8.17% | 10.99B | |
-4.33% | 8.35B | |
+41.80% | 5.67B | |
-21.94% | 4.72B | |
+7.81% | 3.42B | |
-10.26% | 2.76B | |
-10.29% | 2.11B | |
-13.58% | 1.92B |
- Stock Market
- Equities
- 301033 Stock